Product Code: SR112025A1863
The global sleep apnea devices market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
Key Market Segmentation:
Breakup by Product Type:
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- Oral Devices
- Nasal Devices
- Chin Straps
- Others
- Diagnostic Devices
- Actigraphs
- Polysomnography Devices
- Sleep Screening Devices
- Others
Breakup by End-User:
- Hospitals and Clinics
- Sleep Laboratories
- Homecare Settings
- Others
Brealup by Region:
- North America
- United States
- Canada
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Others
- Middle East and Africa
- Turkey
- Saudi Arabia
- Iran
- United Arab Emirates
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.
Key Questions Answered in This Report
- 1.What was the size of the global sleep apnea devices market in 2024?
- 2.What is the expected growth rate of the global sleep apnea devices market during 2025-2033?
- 3.What has been the impact of COVID-19 on the global sleep apnea devices market?
- 4.What are the key factors driving the global sleep apnea devices market?
- 5.What is the breakup of the global sleep apnea devices market based on the product type?
- 6.What is the breakup of the global sleep apnea devices market based on the end-user?
- 7.What are the key regions in the global sleep apnea devices market?
- 8.Who are the key players/companies in the global sleep apnea devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Sleep Apnea Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Therapeutic Devices
- 6.1.1 Market Trends
- 6.1.2 Market Breakup by Type
- 6.1.2.1 Positive Airway Pressure (PAP) Devices
- 6.1.2.1.1 Market Trends
- 6.1.2.1.2 Market Forecast
- 6.1.2.2 Oral Devices
- 6.1.2.2.1 Market Trends
- 6.1.2.2.2 Market Forecast
- 6.1.2.3 Nasal Devices
- 6.1.2.3.1 Market Trends
- 6.1.2.3.2 Market Forecast
- 6.1.2.4 Chin Straps
- 6.1.2.4.1 Market Trends
- 6.1.2.4.2 Market Forecast
- 6.1.2.5 Others
- 6.1.2.5.1 Market Trends
- 6.1.2.5.2 Market Forecast
- 6.1.3 Market Forecast
- 6.2 Diagnostic Devices
- 6.2.1 Market Trends
- 6.2.2 Market Breakup by Type
- 6.2.2.1 Actigraphs
- 6.2.2.1.1 Market Trends
- 6.2.2.1.2 Market Forecast
- 6.2.2.2 Polysomnography Devices
- 6.2.2.2.1 Market Trends
- 6.2.2.2.2 Market Forecast
- 6.2.2.3 Sleep Screening Devices
- 6.2.2.3.1 Market Trends
- 6.2.2.3.2 Market Forecast
- 6.2.2.4 Others
- 6.2.2.4.1 Market Trends
- 6.2.2.4.2 Market Forecast
- 6.2.3 Market Forecast
7 Market Breakup by End-User
- 7.1 Hospitals and Clinics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Sleep Laboratories
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Homecare Settings
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2 Europe
- 8.2.1 Germany
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 France
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 United Kingdom
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 Italy
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Spain
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Russia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3 Asia Pacific
- 8.3.1 China
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 Japan
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 India
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 South Korea
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Australia
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Indonesia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Argentina
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.4 Colombia
- 8.4.4.1 Market Trends
- 8.4.4.2 Market Forecast
- 8.4.5 Chile
- 8.4.5.1 Market Trends
- 8.4.5.2 Market Forecast
- 8.4.6 Peru
- 8.4.6.1 Market Trends
- 8.4.6.2 Market Forecast
- 8.4.7 Others
- 8.4.7.1 Market Trends
- 8.4.7.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Turkey
- 8.5.1.1 Market Trends
- 8.5.1.2 Market Forecast
- 8.5.2 Saudi Arabia
- 8.5.2.1 Market Trends
- 8.5.2.2 Market Forecast
- 8.5.3 Iran
- 8.5.3.1 Market Trends
- 8.5.3.2 Market Forecast
- 8.5.4 United Arab Emirates
- 8.5.4.1 Market Trends
- 8.5.4.2 Market Forecast
- 8.5.5 Others
- 8.5.5.1 Market Trends
- 8.5.5.2 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Competitive Landscape
- 12.1 Market Structure
- 12.2 Key Players
- 12.3 Profiles of Key Players
- 12.3.1 BMC Medical Co.
- 12.3.1.1 Company Overview
- 12.3.1.2 Product Portfolio
- 12.3.2 Braebon Medical Corporation
- 12.3.2.1 Company Overview
- 12.3.2.2 Product Portfolio
- 12.3.3 Cadwell Laboratories Inc.
- 12.3.3.1 Company Overview
- 12.3.3.2 Product Portfolio
- 12.3.4 CareFusion Corp.
- 12.3.4.1 Company Overview
- 12.3.4.2 Product Portfolio
- 12.3.5 Curative Medical Inc.
- 12.3.5.1 Company Overview
- 12.3.5.2 Product Portfolio
- 12.3.6 Devilbiss Healthcare
- 12.3.6.1 Company Overview
- 12.3.6.2 Product Portfolio
- 12.3.7 Fisher & Paykel Healthcare
- 12.3.7.1 Company Overview
- 12.3.7.2 Product Portfolio
- 12.3.7.3 Financials
- 12.3.8 GE Healthcare
- 12.3.8.1 Company Overview
- 12.3.8.2 Product Portfolio
- 12.3.9 Invacare
- 12.3.9.1 Company Overview
- 12.3.9.2 Product Portfolio
- 12.3.9.3 Financials
- 12.3.9.4 SWOT Analysis
- 12.3.10 Oventus Medical
- 12.3.10.1 Company Overview
- 12.3.10.2 Product Portfolio
- 12.3.10.3 Financials
- 12.3.11 Panthera Dental
- 12.3.11.1 Company Overview
- 12.3.11.2 Product Portfolio
- 12.3.12 ResMed
- 12.3.12.1 Company Overview
- 12.3.12.2 Product Portfolio
- 12.3.12.3 Financials
- 12.3.12.4 SWOT Analysis
- 12.3.13 Somnomed Ltd.
- 12.3.13.1 Company Overview
- 12.3.13.2 Product Portfolio
- 12.3.13.3 Financials
- 12.3.14 Vyaire Medical Inc.
- 12.3.14.1 Company Overview
- 12.3.14.2 Product Portfolio
- 12.3.15 Whole You Inc.
- 12.3.15.1 Company Overview
- 12.3.15.2 Product Portfolio